Article
Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Diabetes - 1 Feb 1990
Mandrup-Poulsen T, Mølvig J, Andersen H U, Helqvist S, Spinas G A, Munck M
Abstract excerpt
The effect of immunosuppression on the humoral immune response to islet autoantigens and exogenously administered insulin and the predictive value of islet cell cytoplasmic antibodies (ICAs), insulin antibodies (IAs), and HLA-DR phenotype for remission during immunosuppression were studied in a prospective randomized double-blind trial of cyclosporin administration in 98 newly diagnosed insulin-dependent diabetes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.